NZ204225A - Substituted piperidinoquinazoline derivatives and pharmaceutical compositions - Google Patents
Substituted piperidinoquinazoline derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ204225A NZ204225A NZ204225A NZ20422583A NZ204225A NZ 204225 A NZ204225 A NZ 204225A NZ 204225 A NZ204225 A NZ 204225A NZ 20422583 A NZ20422583 A NZ 20422583A NZ 204225 A NZ204225 A NZ 204225A
- Authority
- NZ
- New Zealand
- Prior art keywords
- dioxide
- quinazoline
- oil
- mixture
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8214206 | 1982-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ204225A true NZ204225A (en) | 1985-12-13 |
Family
ID=10530384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ204225A NZ204225A (en) | 1982-05-15 | 1983-05-13 | Substituted piperidinoquinazoline derivatives and pharmaceutical compositions |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4489075A (forum.php) |
| EP (1) | EP0094766B1 (forum.php) |
| JP (1) | JPS58208289A (forum.php) |
| KR (1) | KR840004747A (forum.php) |
| AU (1) | AU538171B2 (forum.php) |
| CA (1) | CA1195977A (forum.php) |
| DD (2) | DD210269A5 (forum.php) |
| DE (1) | DE3368631D1 (forum.php) |
| DK (1) | DK210183A (forum.php) |
| ES (3) | ES8407039A1 (forum.php) |
| FI (1) | FI831684A7 (forum.php) |
| GR (1) | GR77498B (forum.php) |
| IL (1) | IL68668A0 (forum.php) |
| IN (1) | IN160680B (forum.php) |
| NO (1) | NO831728L (forum.php) |
| NZ (1) | NZ204225A (forum.php) |
| PH (1) | PH18763A (forum.php) |
| PL (2) | PL241968A1 (forum.php) |
| PT (1) | PT76687B (forum.php) |
| SU (1) | SU1194257A3 (forum.php) |
| YU (1) | YU105083A (forum.php) |
| ZA (1) | ZA833422B (forum.php) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| US5138062A (en) * | 1989-10-03 | 1992-08-11 | Philip Morris Incorporated | Nicotine analogs |
| CZ289756B6 (cs) * | 1991-03-28 | 2002-04-17 | Eisai Co., Ltd. | Heterocyklicko-cyklické aminové deriváty, meziprodukty postupu přípravy těchto sloučenin, farmaceutický prostředek a pouľití uvedených derivátů |
| PL3143019T3 (pl) * | 2014-05-15 | 2021-03-22 | Pfizer Inc. | Krystaliczna postać 6-[(4R)-4-metylo-1,2-dioksydo-1,2,6-tiadiazynan-2-ylo]izochinolino-1-karbonitrylu |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971783A (en) * | 1973-03-07 | 1976-07-27 | Pfizer Inc. | 4-Aminoquinazoline derivatives as cardiac stimulants |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| US4171363A (en) * | 1977-02-22 | 1979-10-16 | Bristol-Myers Company | 1,2,3-Thiadiazole process |
| CA1086735A (en) * | 1977-11-03 | 1980-09-30 | John C. Danilewicz | Piperidino-quinazolines |
-
1983
- 1983-04-27 US US06/489,271 patent/US4489075A/en not_active Expired - Fee Related
- 1983-05-05 EP EP83302529A patent/EP0094766B1/en not_active Expired
- 1983-05-05 DE DE8383302529T patent/DE3368631D1/de not_active Expired
- 1983-05-10 IN IN297/DEL/83A patent/IN160680B/en unknown
- 1983-05-11 ES ES522278A patent/ES8407039A1/es not_active Expired
- 1983-05-11 DK DK210183A patent/DK210183A/da not_active Application Discontinuation
- 1983-05-12 IL IL68668A patent/IL68668A0/xx unknown
- 1983-05-12 YU YU01050/83A patent/YU105083A/xx unknown
- 1983-05-13 SU SU833597905A patent/SU1194257A3/ru active
- 1983-05-13 PT PT76687A patent/PT76687B/pt unknown
- 1983-05-13 PL PL24196883A patent/PL241968A1/xx unknown
- 1983-05-13 CA CA000428080A patent/CA1195977A/en not_active Expired
- 1983-05-13 FI FI831684A patent/FI831684A7/fi not_active Application Discontinuation
- 1983-05-13 PH PH28901A patent/PH18763A/en unknown
- 1983-05-13 NO NO831728A patent/NO831728L/no unknown
- 1983-05-13 ZA ZA833422A patent/ZA833422B/xx unknown
- 1983-05-13 AU AU14522/83A patent/AU538171B2/en not_active Ceased
- 1983-05-13 GR GR71346A patent/GR77498B/el unknown
- 1983-05-13 NZ NZ204225A patent/NZ204225A/en unknown
- 1983-05-13 DD DD83250918A patent/DD210269A5/de unknown
- 1983-05-13 DD DD83259680A patent/DD216018A5/de unknown
- 1983-05-13 PL PL24705483A patent/PL247054A1/xx unknown
- 1983-05-14 KR KR1019830002145A patent/KR840004747A/ko not_active Withdrawn
- 1983-05-16 JP JP58085660A patent/JPS58208289A/ja active Pending
- 1983-12-28 ES ES528482A patent/ES8504794A1/es not_active Expired
- 1983-12-28 ES ES528481A patent/ES8504793A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ZA833422B (en) | 1984-02-29 |
| EP0094766A2 (en) | 1983-11-23 |
| DD210269A5 (de) | 1984-06-06 |
| US4489075A (en) | 1984-12-18 |
| YU105083A (en) | 1986-02-28 |
| ES522278A0 (es) | 1984-08-16 |
| AU538171B2 (en) | 1984-08-02 |
| PH18763A (en) | 1985-09-20 |
| PL247054A1 (en) | 1985-03-26 |
| ES528481A0 (es) | 1985-05-01 |
| IN160680B (forum.php) | 1987-07-25 |
| EP0094766B1 (en) | 1986-12-30 |
| SU1194257A3 (ru) | 1985-11-23 |
| FI831684L (fi) | 1983-11-16 |
| ES8504793A1 (es) | 1985-05-01 |
| ES8407039A1 (es) | 1984-08-16 |
| GR77498B (forum.php) | 1984-09-24 |
| FI831684A0 (fi) | 1983-05-13 |
| IL68668A0 (en) | 1983-09-30 |
| DE3368631D1 (de) | 1987-02-05 |
| JPS58208289A (ja) | 1983-12-03 |
| KR840004747A (ko) | 1984-10-24 |
| DK210183A (da) | 1983-11-16 |
| FI831684A7 (fi) | 1983-11-16 |
| NO831728L (no) | 1983-11-16 |
| DD216018A5 (de) | 1984-11-28 |
| AU1452283A (en) | 1983-11-17 |
| PT76687A (en) | 1983-06-01 |
| ES528482A0 (es) | 1985-05-01 |
| PT76687B (en) | 1986-03-27 |
| PL241968A1 (en) | 1984-08-13 |
| CA1195977A (en) | 1985-10-29 |
| EP0094766A3 (en) | 1984-12-12 |
| DK210183D0 (da) | 1983-05-11 |
| ES8504794A1 (es) | 1985-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5494925A (en) | 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof | |
| AU769081B2 (en) | NPY antagonists: spiroisoquinolinone derivatives | |
| US6121258A (en) | 1,5-heterocyclic metalloprotease inhibitors | |
| US4001422A (en) | 4-aminoquinazoline cardiac stimulants | |
| JPH08511028A (ja) | Ｐ物質拮抗剤としてのベンジルオキシキヌクリジン | |
| KR900001204B1 (ko) | 1-[(아미노알킬 및 아미노알킬아미노)카보닐 및 티오카보닐]-α, α-디아릴피롤리딘, 피페리딘 및 호모피페리딘 아세트아미드 및 아세토니트릴의 제조방법 | |
| CA2294549A1 (en) | Heterocyclic substituted piperidines and uses thereof | |
| NZ205472A (en) | 1,4-dihydropyridine derivatives and pharmaceutical compositions | |
| JP2519880B2 (ja) | ピペリジデンジヒドロ−ジベンゾ［ａ，ｂ］シクロヘプテン類およびこれを含有する医薬組成物 | |
| EP0359389A1 (en) | Antiarrhythmic agents | |
| US5556909A (en) | Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof | |
| JPH0351708B2 (forum.php) | ||
| EP0135318B1 (en) | Quinazoline cardiac stimulants | |
| US3468892A (en) | Substituted piperidines | |
| SK33099A3 (en) | Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase | |
| NZ204225A (en) | Substituted piperidinoquinazoline derivatives and pharmaceutical compositions | |
| US4783467A (en) | Tetrahydroimidazoquinazolinone inotropic agents | |
| US20040039045A1 (en) | (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists | |
| US5541168A (en) | Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof | |
| US5602154A (en) | 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof | |
| EP0333027A1 (en) | 4-Pentafluorophenoxypiperidines, a process for their preparation and their use as medicaments | |
| CS270579B2 (en) | Method of new aminoalkanoyl-dibenzo (d,g) (1,3,6) dioxazocines production |